Inhibiting Sterilization-Induced Oxidation of Large Molecule Therapeutics Packaged in Plastic Parenteral Vials

Reference

1. 1.↵
   1. Manning M. C.,
   2. Chou D. K.,
   3. Murphy B. M.,
   4. Payne R. W.,
   5. Katayama D. S.

   Stability of Protein Pharmaceuticals: An Update. Pharm. Res. 2010, 27 (4), 544–575.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Cleland J. L.,
   2. Powell M. F.,
   3. Shire S. J.

   The Development of Stable Protein Formulations—a Close Look at Protein Aggregation, Deamidation, and Oxidation. Crit. Rev. Ther. Drug Carrier Syst. 1993, 10 (4), 307–377.

   OpenUrlPubMedWeb of Science
3. 3.↵
   1. Torosantucci R.,
   2. Schöneich C.,
   3. Jiskoot W.

   Oxidation of Therapeutic Proteins and Peptides: Structural and Biological Consequences. Pharm. Res. 2014, 31 (3), 541–553.

   OpenUrl
4. 4.↵
   1. Costantino H. R.,
   2. Langer R.,
   3. Klibanov A. M.

   Moisture-Induced Aggregation of Lyophilized Insulin. Pharm. Res. 1994, 11 (1), 21–29.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Vogt W.

   Oxidation of Methionyl Residues in Proteins—Tools, Targets, and Reversal. Free Radical Bio. Med. 1995, 18 (1), 93–105.

   OpenUrl
6. 6.↵
   1. Li S. H.,
   2. Schoneich C.,
   3. Wilson G. S.,
   4. Borchardt R. T.

   Chemical Pathways of Peptide Degradation. V. Ascorbic-Acid Promotes Rather Than Inhibits the Oxidation of Methionine to Methionine Sulfoxide in Small Model Peptides. Pharm. Res. 1993, 10 (11), 1572–1579.

   OpenUrlPubMed
7. 7.↵
   1. Fransson J.,
   2. FlorinRobertsson E.,
   3. Axelsson K.,
   4. Nyhlen C.

   Oxidation of Human Insulin-like Growth Factor I in Formulation Studies: Kinetics of Methionine Oxidation in Aqueous Solution and in Solid State. Pharm Res 1996, 13 (8), 1252–1257.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Shoyele S. A.,
   2. Sivadas N.,
   3. Cryan S.-A.

   The Effects of Excipients and Particle Engineering on the Biophysical Stability and Aerosol Performance of Parathyroid Hormone (1-34) Prepared as a Dry Powder for Inhalation. AAPS PharmSciTech 2011, 12 (1), 304–311.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Sacha G. A.,
   2. Saffell-Clemmer W.,
   3. Abram K.,
   4. Akers M. J.

   Practical Fundamentals of Glass, Rubber, and Plastic Sterile Packaging Systems. Pharm. Dev. Technol. 2010, 15 (1), 6–34.

   OpenUrlPubMed
10. 10.↵
    1. Schaut R. A.,
    2. Weeks W. P.

    Historical Review of Glasses Used for Parenteral Packaging. PDA J Pharm Sci Technol. 2017, 71 (4), 279–296.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Iacocca R. G.,
    2. Toltl N.,
    3. Allgeier M.,
    4. Bustard B.,
    5. Dong X.,
    6. Foubert M.,
    7. Hofer J.,
    8. Peoples S.,
    9. Shelbourn T.

    Factors Affecting the Chemical Durability of Glass Used in the Pharmaceutical Industry. AAPS PharmSciTech 2010, 11 (3), 1340–1349.

    OpenUrlPubMed
12. 12.↵
    1. Zhao J.,
    2. Lavalley V.,
    3. Mangiagalli P.,
    4. Wright J. M.,
    5. Bankston T. E.

    Glass Delamination: a Comparison of the Inner Surface Performance of Vials and Pre-filled Syringes. AAPS PharmSciTech 2014, 15 (6), 1398–1409.

    OpenUrl
13. 13.↵
    1. Niles W. D.,
    2. Coassin P. J.

    Cyclic Olefin Polymers: Innovative Materials for High-Density Multiwell Plates. Assay Drug Dev. Technol. 2008, 6 (4), 577–590.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    1. Mayers C. L.,
    2. Jenke D. R.

    Stabilization of Oxygen-Sensitive Formulations via a Secondary Oxygen Scavenger. Pharm Res 1993, 10 (3), 445–448.

    OpenUrlPubMed
15. 15.↵
    1. Nakamura K.,
    2. Abe Y.,
    3. Kiminami H.,
    4. Yamashita A.,
    5. Iwasaki K.,
    6. Suzuki S.,
    7. Yoshino K.,
    8. Dierick W.,
    9. Constable K.

    A Strategy for the Prevention of Protein Oxidation by Drug Product in Polymer-based Syringes. PDA J. Pharm. Sci. Technol. 2015, 69 (1), 88–95.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Chatham H.

    Oxygen Diffusion Barrier Properties of Transparent Oxide Coatings on Polymeric Substrates. Surface and Coatings Technology 1996, 78 (1-3), 1–9.

    OpenUrl
17. 17.↵
    1. Walther M.,
    2. Heming M.,
    3. Spallek M.

    Multilayer Barrier Coating System Produced by Plasma-Impulse Chemical Vapor Deposition (PICVD). Surface and Coatings Technology 1996, 80 (1-2), 200–202.

    OpenUrl
18. 18.↵
    1. Leterrier Y.

    Durability of Nanosized Oxygen-Barrier Coatings on Polymers. Progress in Materials Science 2003, 48 (1), 1–55.

    OpenUrl
19. 19.↵
    1. da Silva Sobrinho A. S.,
    2. Latrèche M.,
    3. Czeremuszkin G.,
    4. Klemberg-Sapieha J. E.,
    5. Wertheimer M. R.

    Transparent Barrier Coatings on Polyethylene Terephthalate by Single- and Dual-Frequency Plasma-Enhanced Chemical Vapor Deposition. Journal of Vacuum Science & Technology A: Vacuum, Surfaces, and Films 1998, 16 (6), 3190–3198.

    OpenUrl
20. 20.↵
    1. Danielzik B.,
    2. Mohl W.,
    3. Spallek M.,
    4. Walther M.

    High Rate Coatings for Diffusion Barriers by Plasma Impulse Chemical Vapour Deposition. Proceedings of the Annual Technical Conference—Society of Vacuum Coaters, 1996.
21. 21.↵
    1. Frelinger A. L.,
    2. Zull J. E.

    Oxidized Forms of Parathyroid-Hormone with Biological-Activity—Separation and Characterization of Hormone Forms Oxidized at Methionine-8 and Methionine-18. J. Biol. Chem. 1984, 259 (9), 5507–5513.

    OpenUrlAbstract/FREE Full Text
22. 22.↵
    1. Nabuchi Y.,
    2. Fujiwara E.,
    3. Ueno K.,
    4. Kuboniwa H.,
    5. Asoh Y.,
    6. Ushio H.

    Oxidation of Recombinant Human Parathyroid Hormone: Effect of Oxidized Position on the Biological Activity. Pharm. Res. 1995, 12 (12), 2049–2052.

    OpenUrlCrossRefPubMedWeb of Science
23. 23.↵
    1. Ohta M.,
    2. Kawasaki N.,
    3. Hyuga S.,
    4. Hyuga M.,
    5. Hayakawa T.

    Selective Glycopeptide Mapping of Erythropoietin by On-Line High-Performance Liquid Chromatography–Electrospray Ionization Mass Spectrometry. J. Chromatogr., A 2001, 910 (1), 1–11.

    OpenUrlCrossRefPubMed
24. 24.↵
    1. Zull J. E.,
    2. Smith S. K.,
    3. Wiltshire R.

    Effect of Methionine Oxidation and Deletion of Amino-Terminal Residues on the Conformation of Parathyroid-Hormone—Circular-Dichroism Studies. J. Biol. Chem. 1990, 265 (10), 5671–5676.

    OpenUrlAbstract/FREE Full Text
25. 25.↵
    1. Kamberi M.,
    2. Kim Y. J.,
    3. Jun B.,
    4. Riley C. M.

    The Effects of Sucrose on Stability of Human Brain Natriuretic Peptide [hBNP (1-32)] and Human Parathyroid Hormone [hPTH (1-34)]. J. Peptide Res. 2008, 66 (6), 348–356.

    OpenUrl
26. 26.↵
    1. Lai P. H.,
    2. Everett R.,
    3. Wang F. F.,
    4. Arakawa T.,
    5. Goldwasser E.

    Structural Characterization of Human Erythropoietin. J. Biol. Chem. 1986, 261 (7), 3116–3121.

    OpenUrlAbstract/FREE Full Text
27. 27.↵
    1. Labrenz S. R.,
    2. Calmann M. A.,
    3. Heavner G. A.,
    4. Tolman G.

    The Oxidation of Methionine-54 of Epoetinum Alfa Does Not Affect Molecular Structure or Stability, but Does Decrease Biological Activity. PDA J. Pharm. Sci. Technol. 2008, 62 (3), 211–223.

    OpenUrlAbstract/FREE Full Text